Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Topical ophthalmic peptide formulation

Topical ophthalmic peptide formulation

US Patent 9216208 · Granted Dec 22, 2015

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Cortistatin analogues for the treatment of inflammatory and/or immune diseases2025
Cortistatin analogues for the treatment of inflammatory and/or immune diseases2025
Dipeptidyl peptidase-4 inhibitors for topical eye treatment of retinal neurodege2024
Dipeptidyl peptidase-4 inhibitors for topical eye treatment of retinal neurodege2024
Bicalutamide analogs or (S)-bicalutamide as exocytosis activating compounds for 2023
Dipeptidyl peptidase-4 inhibitors for topical eye treatment of retinal neurodege2021
Dipeptidyl peptidase-4 inhibitors for topical eye treatment of retinal neurodege2021
Sex hormone-binding globulin for use as a medicament2020
Sex hormone-binding globulin for use as a medicament2020
Topical ophthalmic formulations of endothelin receptor antagonists2020
Topical ophthalmic formulations of endothelin receptor antagonists2020
SOCS1-derived peptide for use in chronic complications of diabetes2020